Phase II Study With Ga101-DHAP as Induction Therapy in Relapsed/Refractory DLBCL Patients

NCT02374424 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
29
Enrollment
OTHER
Sponsor class

Stopped Interim analysis planned as per protocol didn't provide positive outcome therefore enrollment was not reopened. However, the enrolled patients concluded therapy and continued into the follow-up phase. The study was closed only after LVLP.

Conditions

Interventions

Sponsor

Fondazione Italiana Linfomi - ETS